Navigation Links
Soligenix Announces Initiation of a Phase 1/2 Clinical Trial of SGX201 for the Prevention of Acute Radiation Enteritis
Date:12/21/2009

ing the bowel, leading to acute and chronic toxicities. The large and small bowels are very sensitive to radiation. The larger the dose of radiation, the greater the potential damage to normal bowel tissue. Most tumors in the abdomen and pelvis need large doses, and almost all patients receiving radiation to the abdomen, pelvis or rectum will show signs of acute enteritis.

Patients with acute enteritis may have nausea, vomiting, abdominal pain and bleeding, among other symptoms. Some patients may develop dehydration and require hospitalization. With diarrhea, the gastrointestinal tract does not function normally, and nutrients such as fat, lactose, bile salts and vitamin B12 are not well absorbed.

Symptoms will usually resolve within 2-6 weeks after therapy has ceased. Radiation enteritis is often not a self-limited illness, as over 80% of patients who receive abdominal radiation therapy complain of a persistent change in bowel habits. Moreover, acute radiation injury increases the risk of development of chronic radiation enteropathy, and overall 5% to 15% of the patients who receive abdominal or pelvic irradiation will develop chronic radiation enteritis.

About SGX201

SGX201 contains BDP, a highly potent, topically active corticosteroid that has a local effect on inflamed tissue. BDP has been marketed in the United States and worldwide since the early 1970s as the active pharmaceutical ingredient in inhalation products for the treatment of patients with allergic rhinitis and asthma. BDP is also the active ingredient in orBec®, currently in Phase 3 and Phase 2 development by Soligenix for the treatment and prevention of acute Graft-versus-Host disease (GVHD), respectively. SGX201 is a time-release formulation of BDP specifically designed for oral use. SGX201 has been awarded fast-track designation from the FDA for the treatment of radiation enteritis.

About Soligenix, Inc.

Soligeni
'/>"/>

SOURCE Soligenix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)...  Luminex Corporation (NASDAQ: LMNX ) today ... 30, 2014. Financial and operating highlights include the following: ... million, a 2 percent increase over the second quarter ... $8.3 million, a 9 percent increase over the second ... 268 multiplexing analyzers, which included 148 LX systems, 96 ...
(Date:7/28/2014)... 2014 /PRNewswire-iReach/ -- June 28 th , 2014 – Oncolab, ... the AMAS cancer test, is making its AACC debut (booth ... test, which is a serum-based in vitro immunoassay, has been ... significant tool in the fight against cancer recurrence. ... estimated 17 million cancer survivors in the US alone, the ...
(Date:7/28/2014)...  Air Products (NYSE: APD ) understands ... vital to any healthcare facility. This understanding has driven ... the efficiency of its oxygen supply systems, but also ... systems for emergency oxygen supply and high ... the 51 st ASHE Annual Conference & ...
Breaking Medicine Technology:Luminex Corporation Reports Second Quarter 2014 results 2Luminex Corporation Reports Second Quarter 2014 results 3Luminex Corporation Reports Second Quarter 2014 results 4Luminex Corporation Reports Second Quarter 2014 results 5Luminex Corporation Reports Second Quarter 2014 results 6Luminex Corporation Reports Second Quarter 2014 results 7Luminex Corporation Reports Second Quarter 2014 results 8Luminex Corporation Reports Second Quarter 2014 results 9Luminex Corporation Reports Second Quarter 2014 results 10Luminex Corporation Reports Second Quarter 2014 results 11Luminex Corporation Reports Second Quarter 2014 results 12Luminex Corporation Reports Second Quarter 2014 results 13Luminex Corporation Reports Second Quarter 2014 results 14Luminex Corporation Reports Second Quarter 2014 results 15Luminex Corporation Reports Second Quarter 2014 results 16Luminex Corporation Reports Second Quarter 2014 results 17Oncolab, Inc. Exhibits Pioneering AMAS Cancer Test at AACC 2Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 2Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 3
... BOSTON, Feb. 16, 2011 MedAptus®, the market ... New England Baptist Hospital (NEBH) has selected the ... inpatient medicine providers. The NEBH hospitalist team, comprised ... MedAptus, Inpatient Edition via the web as well ...
... Feb. 15, 2011 Warner Chilcott plc (Nasdaq: WCRX ... full year 2010 financial results prior to the market opening on ... a press release, the Company will host a conference call for ... (Eastern Time) to review the results. To participate in the call, ...
Cached Medicine Technology:Hospitalists at New England Baptist Hospital Choose MedAptus 2
(Date:7/28/2014)... 2014 Ticket Down is reliable ... in Dallas, TX at the Cotton Bowl. The 2014 ... USA and it is an eight team tourney. The ... including teams from La Liga, Serie A, English Premier League, ... it out on the pitch include: Manchester United, Manchester ...
(Date:7/28/2014)... 2014 Cape Regional Medical Center, ... technology solution in an effort to streamline ... collaboration with their New Jersey health information exchange ... located in New Jersey, serves the local population ... variety of inpatient and outpatient services. With a ...
(Date:7/28/2014)... (HealthDay News) -- British researchers report that an alternative ... around. In their experiments, the scientists found that ... one person to the other than what is known ... exchange might suffice as a cultural substitute for the ... in the August issue of the American Journal ...
(Date:7/28/2014)... SIMpalm helped its client to launch ... on iTunes for download . Experience a new way ... you to listen and cook along with expert real-time audio ... out the ingredients and equipment, press play, and follow the ... ahead of time, just relax and cook along with us. ...
(Date:7/28/2014)... LA JOLLAWhen you,re expecting somethinglike the meal you,ve ... interest, unique electrical rhythms sweep through your brain. ... and they reflect a symphony of cellsboth excitatory ... their role has been debated, gamma waves have ... in the patterns have been tied to schizophrenia, ...
Breaking Medicine News(10 mins):Health News:Real Madrid vs. AS Roma Tickets Cotton Bowl Dallas, TX: Ticket Down Cuts Ticket Prices for AS Roma vs. Real Madrid International Champions Cup Tickets 2Health News:Real Madrid vs. AS Roma Tickets Cotton Bowl Dallas, TX: Ticket Down Cuts Ticket Prices for AS Roma vs. Real Madrid International Champions Cup Tickets 3Health News:Cape Regional Medical Center Chooses Summit Provider Exchange to Connect With NJSHINE and Physician Offices 2Health News:Cape Regional Medical Center Chooses Summit Provider Exchange to Connect With NJSHINE and Physician Offices 3Health News:'Fist Bump' May Beat Handshake for Cleanliness 2Health News:'Fist Bump' May Beat Handshake for Cleanliness 3Health News:Audio Chef Co. Releases Audio Cooking App for iPhone/iPad/iPod touch 2Health News:Audio Chef Co. Releases Audio Cooking App for iPhone/iPad/iPod touch 3Health News:Audio Chef Co. Releases Audio Cooking App for iPhone/iPad/iPod touch 4Health News:Memory relies on astrocytes, the brain's lesser known cells 2Health News:Memory relies on astrocytes, the brain's lesser known cells 3
... ... warning concerning the osteoporosis drug Fosamax as The Sanders Firm prepares for the first ... ... States Food and Drug Administration, via its website at FDA.gov , has issued ...
... the California Dental Association (CDA) Foundation has released new guidelines designed to emphasize the safety of dental treatment during pregnancy and ensure women the services they need. , ... , ... ... ...
... ... same HCG diet that doctors are charging thousands of dollars for. , ... (PRWEB) March 15, 2010 -- YourHCG.com ... plans. YourHCG.com has helped over 50,000 people lose weight for about 10% of what the ...
... MISSISSAUGA, ON , March 15 /PRNewswire-FirstCall/ - Nuvo ... on the research and development of drug products that are ... transdermal drug delivery technologies, and on the development of its ... enrolled the first patient in its European Phase 2 clinical ...
... eight times more likely to die, study finds , MONDAY, March ... hip are five to eight times more likely to die in ... Belgian researchers has found. , And, while the death rate after ... the break, it never returns to the death rate seen in ...
... link between obesity and disease has been well documented. There,s ... as they,ve shown in the United States at least 90,000 ... of Alberta researcher Richard Lamb is on his way to ... the scientific process works. Lamb is studying a cell ...
Cached Medicine News:Health News:The Sanders Firm is Assigned the First Fosamax Trial 2Health News:The Sanders Firm is Assigned the First Fosamax Trial 3Health News:California Dental Association Foundation Releases New Oral Health Guidelines for Pregnant Women 2Health News:California Dental Association Foundation Releases New Oral Health Guidelines for Pregnant Women 3Health News:California Dental Association Foundation Releases New Oral Health Guidelines for Pregnant Women 4Health News:YourHCG.com Changes the Way People Lose Weight by Offering an Affordable HCG Diet Plan 2Health News:Nuvo Research enrolls first patient in Phase 2 WF10 allergic rhinitis trial 2Health News:Nuvo Research enrolls first patient in Phase 2 WF10 allergic rhinitis trial 3Health News:Nuvo Research enrolls first patient in Phase 2 WF10 allergic rhinitis trial 4Health News:Nuvo Research enrolls first patient in Phase 2 WF10 allergic rhinitis trial 5Health News:Risk of Death Persists After a Hip Fracture 2Health News:Risk of Death Persists After a Hip Fracture 3
The DSL-10-3000 ACTIVE Ferritin Enzyme-Linked Immunosorbent (ELISA) Kit provides materials for the quantitative measurement of ferritin in serum....
... Bio-Rad isotopic anemia ... and minimal ,pipetting steps ... information about the processes ... and the benefit to ...
... Bio-Rad isotopic anemia ... and minimal ,pipetting steps ... information about the processes ... and the benefit to ...
... Bio-Rad isotopic anemia assays ... minimal ,pipetting steps for ... about the processes ,involved ... the benefit to your ...
Medicine Products: